Clinical Study
Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P
Full Title
A Single-center, Open-label, Randomized, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile, Pharmacodynamics, Safety and Tolerability of Four P3P Variants in Smoking Healthy Adult Subjects
Authored by
PMI
Abstract
This is a single-center, open-label, randomized, crossover study to evaluate the pharmacokinetic (PK) profiles of four P3P variants, following a fixed puffing regimen and an ad libitum use period. In addition, pharmacodynamic (PD) effects (subjective effects and related behavioral assessments), as well as human puffing topography, will be evaluated, to provide further insights on product acceptance and product use.
Summary
Recruitment | Completed |
Study Results | No Results Available |
Enrollment | 18 |
Study Type | Interventional (Clinical Trial) |
Other IDs | P3P-PK-01-CH |
-
Published On
December 12, 2017 -
Full publication
-
Identifier
NCT03369340